Stem cell therapy for Crohn's & IBD — for patients from Canada

If you are researching Crohn's & IBD treatment from Canada, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €5,500–€18,400. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.

How Crohn's & IBD is treated

Crohn's disease and ulcerative colitis (inflammatory bowel disease, IBD) involve chronic intestinal inflammation driven by aberrant immune responses to commensals and barrier dysfunction. Current therapies (aminosalicylates, corticosteroids, biologics) suppress inflammation but do not repair underlying mucosal defects or fully restore immune tolerance. Stem cell strategies exploit the immunoregulatory capacity of placental mesenchymal stem cells (MSCs), which secrete anti-inflammatory cytokines (IL-10, TGF-β) and promote regulatory T cell differentiation. MSCs also enhance barrier integrity by supporting tight-junction proteins and promoting mucosal healing. A particularly important development: darvadstrocel, an allogeneic MSC product, recently obtained European Union conditional approval for treatment of complex perianal Crohn's fistulae—marking the first regulatory recognition of cell therapy for IBD. Beyond this niche indication, systemic MSC therapy for induction remission and maintenance is investigational across 89 registered trials globally; thirteen actively recruit. It is delivered under a physician-led protocol and designed to complement your existing care.

Your cost from Canada

Cost ranges are indicative market figures for planning, not quotes.